Ticker
LEXXCompany Name
LEXARIA BIOSCIENCE CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -11.39M | -1849.39% | $ 615.92K |
3/31/2025 | $ -9.38M | -1784.18% | $ 525.92K |
12/31/2024 | $ -7.32M | -1473.01% | $ 496.92K |
9/30/2024 | $ -5.8M | -1248.25% | $ 464.28K |
6/30/2024 | $ -4.83M | -1280.99% | $ 376.85K |
3/31/2024 | $ -5.44M | -1409.68% | $ 386K |
12/31/2023 | $ -6.11M | -2215.46% | $ 276.01K |
9/30/2023 | $ -6.71M | -2967.41% | $ 226.21K |
6/30/2023 | $ -7M | -2054.41% | $ 340.79K |
3/31/2023 | $ -7.02M | -2022.11% | $ 347.36K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for LEXARIA BIOSCIENCE CORP is calculated as follows: EBIT [ $ -4.08M ] / Revenues [ $ 384.54K ]
(=) EBIT % [ -1062.2% ]
Minimum
Jun 30, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |